Trinity Biotech PLC TRIB
Trinity Biotech PLC (Nasdaq: TRIB) is an endocrine/women's health diagnostics company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| Uni-Gold HIV / TrinScreen HIV point-of-care tests | HIV | unclear | NA_NON_THERAPEUTIC |
| Clinical laboratory diagnostics (HbA1c, autoimmune, infectious disease) | diagnostic testing | unclear | NA_NON_THERAPEUTIC |
| CGM wearable biosensor (Waveform assets) | diabetes monitoring | device-combination | NA_NON_THERAPEUTIC |
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other endocrine/women's health companies
- Tandem Diabetes Care Inc TNDM
- Beta Bionics, Inc. BBNX
- Utah Medical Products Inc UTMD
- Femasys Inc FEMY
- Pulsenmore Ltd. PLSM
- INVO Fertility, Inc. IVF
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.